UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370

[1]  Z. Ren,et al.  miR-450b-5p loss mediated KIF26B activation promoted hepatocellular carcinoma progression by activating PI3K/AKT pathway , 2019, Cancer Cell International.

[2]  R. Sun,et al.  Expression patterns and prognostic value of m6A-related genes in colorectal cancer. , 2019, American journal of translational research.

[3]  Juan Li,et al.  Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer , 2019, Molecular Cancer.

[4]  Y. Shiloh,et al.  UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors , 2019, Cell.

[5]  Juan Li,et al.  MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway , 2018, Cell Death & Disease.

[6]  Juan Li,et al.  MiR‐139‐5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma , 2018, Cell proliferation.

[7]  J. Llovet,et al.  Molecular therapies and precision medicine for hepatocellular carcinoma , 2018, Nature Reviews Clinical Oncology.

[8]  Hong Lin,et al.  The UbL-UBA Ubiquilin4 protein functions as a tumor suppressor in gastric cancer by p53-dependent and p53-independent regulation of p21 , 2018, Cell Death & Differentiation.

[9]  Mei Zhao,et al.  Overexpression of the Ubiquilin-4 (UBQLN4) is Associated with Cell Cycle Arrest and Apoptosis in Human Normal Gastric Epithelial Cell Lines GES-1 Cells by Activation of the ERK Signaling Pathway , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[10]  C. la Vecchia,et al.  Global trends and predictions in hepatocellular carcinoma mortality. , 2017, Journal of hepatology.

[11]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[12]  Yizhi Chen,et al.  Prognostic significance of Ubiquilin1 expression in invasive breast cancer. , 2015, Cancer biomarkers : section A of Disease markers.

[13]  W. Lockwood,et al.  Ubiquilin1 Represses Migration and Epithelial to Mesenchymal Transition of Human Non-small Cell Lung Cancer Cells , 2014, Oncogene.

[14]  W. Lockwood,et al.  Abstract A05: Ubiquilin1 represses migration and epithelial to mesenchymal transition of human non-small cell lung cancer cells. , 2014 .

[15]  C. Croce,et al.  MicroRNAs in cancer. , 2014, Annual review of pathology.

[16]  C. Niehrs.  The complex world of WNT receptor signalling , 2012, Nature Reviews Molecular Cell Biology.

[17]  A. Covey,et al.  Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma , 2012, CA: a cancer journal for clinicians.

[18]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[19]  E. Brown,et al.  Ubiquilins in the crosstalk among proteolytic pathways , 2012, Biological chemistry.

[20]  J. Bruix,et al.  Hepatocellular carcinoma , 2012, The Lancet.

[21]  Paul Polakis,et al.  Wnt signaling in cancer. , 2012, Cold Spring Harbor perspectives in biology.

[22]  H. Varmus,et al.  Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1 , 2012, Proceedings of the National Academy of Sciences.

[23]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[24]  C. Croce,et al.  Targeting microRNAs in cancer: rationale, strategies and challenges , 2010, Nature Reviews Drug Discovery.

[25]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[26]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[27]  Ajamete Kaykas,et al.  WNT and β-catenin signalling: diseases and therapies , 2004, Nature Reviews Genetics.

[28]  Randall T Moon,et al.  WNT and beta-catenin signalling: diseases and therapies. , 2004, Nature reviews. Genetics.

[29]  P. Howley,et al.  The ubiquitin-associated domain of hPLIC-2 interacts with the proteasome. , 2003, Molecular biology of the cell.

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[31]  P. Howley,et al.  The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. , 2000, Molecular cell.

[32]  D. Conklin,et al.  Molecular cloning, chromosome mapping and characterization of UBQLN3 a testis-specific gene that contains an ubiquitin-like domain. , 2000, Gene.

[33]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.